The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Calcimimetics with potent and selective activity on the parathyroid calcium receptor
Open accessAbstract
Parathyroid hormone (PTH) secretion is regulated by a cell surface Ca 2+ receptor that detects small changes in the level of plasma Ca 2+ . Because this G protein-coupled receptor conceivably provides a distinct molecular target for drugs useful in treating bone and mineral-related disorders, we sought to design small organic molecules that act on the Ca 2+ receptor. We discovered that certain phenylalkylamine compounds, typified by NPS R-568 and its deschloro derivative NPS R-467, increased the concentration of cytoplasmic Ca 2+ ([Ca 2+ ] i ) in bovine parathyroid cells and inhibited PTH secretion at nanomolar concentrations. These effects were stereoselective and the R enantiomers were 10- to 100-fold more potent than the S enantiomers. NPS R-568 potentiated the effects of extracellular Ca 2+ on [Ca 2+ ] i and PTH secretion but was without effect in the absence of extracellular Ca 2+ . Both compounds shifted the concentration–response curves for extracellular Ca 2+ to the left. Presumably, these compounds act as positive allosteric modulators to increase the sensitivity of the Ca 2+ receptor to activation by extracellular Ca 2+ . Both NPS R-467 and NPS R-568 increased [Ca 2+ ] i in HEK 293 cells expressing the human parathyroid Ca 2+ receptor but were without effect in wild-type HEK 293 cells. Neither compound affected the cytoplasmic Ca 2+ responses elicited by several other G protein-coupled receptors in HEK 293 cells or in bovine parathyroid cells. Significantly, these compounds did not affect responses elicited by the homologous metabotropic glutamate receptors, mGluR1a, mGluR2, or mGluR8. These compounds therefore act selectively on the Ca 2+ receptor. Compounds that mimic or potentiate the effects of extracellular Ca 2+ at the Ca 2+ receptor are termed calcimimetics. The discovery of calcimimetic compounds with potent and selective activity enables a pharmacological approach to regulating plasma levels of PTH. Calcimimetic compounds could conceivably provide a specific medical therapy for primary hyperparathyroidism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cloning and characterization of an extracellular Ca2+-sensing receptor from bovine parathyroid
Brown, E. M., Gamba, G., Riccardi, D., Lombardi, M., Butters, R., Kifor, O., Sun, A., Hediger, M. A., Lytton, J., & Hebert, S. C. (1993) · Nature · doi:10.1038/366575a0 · Cited by 2,643
Principles of Bone Biology: By Bilezikian, Raisz and Rodan. Academic Press, London, U.K., 1996
Compston, J. E. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.2431019.x · Cited by 1,370
Brown, E. M. (1991) · Physiological Reviews · doi:10.1152/physrev.1991.71.2.371 · Cited by 690
Silverberg, S. J., Bone, H. G., Marriott, T. B., Locker, F. G., Thys-Jacobs, S., Dziem, G., Kaatz, S., Sanguinetti, E. L., & Bilezikian, J. P. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711203372104 · Cited by 260
&NA; (1998) · The Endocrinologist · doi:10.1097/00019616-199803000-00017 · Cited by 254
CHEN, C. J., Barnett, J. V., CONGO, D. A., & Brown, E. M. (1989) · Endocrinology · doi:10.1210/endo-124-1-233 · Cited by 131
Saugstad, J. A., Segerson, T. P., & Westbrook, G. L. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-19-05979.1996 · Cited by 118
High Calcium and Other Divalent Cations Increase Inositol Trisphosphate in Bovine Parathyroid Cells*
Shoback, D., MEMBRENO, L. A., & McGHEE, J. G. (1988) · Endocrinology · doi:10.1210/endo-123-1-382 · Cited by 109
Muff, R., Nemeth, E. F., Haller-Brem, S., & Fischer, J. A. (1988) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(88)90378-5 · Cited by 75
Self-citationMetabotropic glutamate receptors: potential drug targets
Knöpfel, T., & Gasparini, F. (1996) · Drug Discovery Today · doi:10.1016/1359-6446(96)89038-6 · Cited by 21
Cited by
Extracellular Calcium Sensing and Extracellular Calcium Signaling
Brown, E. M., & MacLeod, R. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.1.239 · Cited by 1,388
Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis
Block, G. A., Martin, K. J., de Francisco, A. L. M., Turner, S. A., Avram, M. M., Suranyi, M. G., Hercz, G., Cunningham, J., Abu-Alfa, A. K., Messa, P., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031633 · Cited by 1,139
Fraser, W. D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60507-9 · Cited by 934
Allosteric Modulation of G Protein–Coupled Receptors
May, L. T., Leach, K., Sexton, P. M., & Christopoulos, A. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105159 · Cited by 695
Evolution, structure, and activation mechanism of family 3/C G-protein-coupled receptors
Pin, J.-P., Galvez, T., & Prézeau, L. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(03)00038-x · Cited by 662
Extracellular calcium sensing and signalling
Hofer, A. M., & Brown, E. M. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1154 · Cited by 612
Block, G. A., & Port, F. K. (2000) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(00)70064-3 · Cited by 594
The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12445 · Cited by 556
Recent Natural Products Based Drug Development: A Pharmaceutical Industry Perspective
Shu, Y.-Z. (1998) · Journal of Natural Products · doi:10.1021/np9800102 · Cited by 517
l -Amino acid sensing by the extracellular Ca 2+ -sensing receptor
Conigrave, A. D., Quinn, S. J., & Brown, E. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.9.4814 · Cited by 502
Peacock, M., Bilezikian, J. P., Klassen, P. S., Guo, M. D., Turner, S. A., & Shoback, D. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0842 · Cited by 471
Lindberg, J. S., Culleton, B., Wong, G., Borah, M. F., Clark, R. V., Shapiro, W. B., Roger, S. D., Husserl, F. E., Klassen, P. S., Guo, M. D., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004060512 · Cited by 413
Pharmacodynamics of the Type II Calcimimetic Compound Cinacalcet HCl
Nemeth, E. F., Heaton, W. H., Miller, M., Fox, J., Balandrin, M. F., Van Wagenen, B. C., Colloton, M., Karbon, W., Scherrer, J., Shatzen, E., et al. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.057273 · Cited by 369
Self-citationPhysiology and pathophysiology of the calcium-sensing receptor in the kidney
Riccardi, D., & Brown, E. M. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00608.2009 · Cited by 359
Identification of a Novel Extracellular Cation-sensing G-protein-coupled Receptor
Pi, M., Faber, P., Ekema, G., Jackson, P. D., Ting, A., Wang, N., Fontilla-Poole, M., Mays, R. W., Brunden, K. R., Harrington, J. J., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505186200 · Cited by 316
THE CALCIUM-SENSING RECEPTOR IN NORMAL PHYSIOLOGY AND PATHOPHYSIOLOGY: A Review
Tfelt-Hansen, J., & Brown, E. M. (2005) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360590886606 · Cited by 289
Goodman, W. G., Hladik, G. A., Turner, S. A., Blaisdell, P. W., Goodkin, D. A., Liu, W., Barri, Y. M., Cohen, R. M., & Coburn, J. W. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1341017 · Cited by 281
Gowen, M., Stroup, G. B., Dodds, R. A., James, I. E., Votta, B. J., Smith, B. R., Bhatnagar, P. K., Lago, A. M., Callahan, J. F., DelMar, E. G., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9038 · Cited by 279
Self-citationHendy, G. N., D'Souza-Li, L., Yang, B., Canaff, L., & Cole, D. E. C. (2000) · Human Mutation · doi:10.1002/1098-1004(200010)16:4<281::aid-humu1>3.0.co;2-a · Cited by 277
Cinacalcet Hydrochloride Reduces the Serum Calcium Concentration in Inoperable Parathyroid Carcinoma
Silverberg, S. J., Rubin, M. R., Faiman, C., Peacock, M., Shoback, D. M., Smallridge, R. C., Schwanauer, L. E., Olson, K. A., Klassen, P., & Bilezikian, J. P. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0585 · Cited by 274
Kifor, O., MacLeod, R. J., Diaz, R., Bai, M., Yamaguchi, T., Yao, T., Kifor, I., & Brown, E. M. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.280.2.f291 · Cited by 273
Calcium and phosphate homeostasis: Concerted interplay of new regulators
Renkema, K. Y., Alexander, R. T., Bindels, R. J., & Hoenderop, J. G. (2008) · Annals of Medicine · doi:10.1080/07853890701689645 · Cited by 263
“Treatment of hypercalcemia depends on the severity of the abnormality and ranges from dietary adaptation to the administration of calcimimetic compounds that activate the CaSR in the parathyroid glands, reducing blood PTH levels (56).”
Background
Metadata
- Authors
- Nemeth, E. F., Steffey, M. E., Hammerland, L. G., Hung, B. C. P., Van Wagenen, B. C., DelMar, E. G., & Balandrin, M. F.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1998-03-31
- Volume
- 95
- Issue
- 7
- Pages
- 4040-4045
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2086766564
- Cited by
- 610
- References
- 10
- FWCI
- 22.34
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.